Charity-run funds that are helping patients pay high co-payments are facing new scrutiny by prosecutors. The Department of Health has stepped up their oversight of patient groups’ relationships with pharmaceutical companies in an effort to stop groups favoring patients on certain drugs.
Published by Jayne O’Donnell on 6/8/16
In a recent article in the Bristol Herald Courier, David Balto gives a great summary of the problems with the pharmacy benefit management industry, such
In a recent article at BenefitsPRO, Dan Cook talks about the movement to have employers “rise up and fight their own battles with the drug
“Today, one in four Americans who need prescription drugs struggle to afford them — one in four,” president Joe Biden. The last two administrations have
